Aggressive Marginal Zone Lymphoma (MZL)
1 clinical trials · Condition
◉ Watch Aggressive Marginal Zone Lymphoma (MZL)
| Record | Firm | Date |
|---|---|---|
| Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP (NCT02983097) | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | 2010-11-01 |
Track Aggressive Marginal Zone Lymphoma (MZL) automatically
Every clearance here is in the API, with alerts when new ones post.